Back to Search Start Over

Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review.

Authors :
Yarlas, Aaron
Bayliss, Martha
Cappelleri, Joseph C.
Maher, Stephen
Bushmakin, Andrew G.
Chen, Lea Ann
Manuchehri, Alireza
Healey, Paul
Source :
Quality of Life Research; Feb2018, Vol. 27 Issue 2, p273-290, 18p, 1 Diagram, 10 Charts
Publication Year :
2018

Abstract

<bold>Purpose: </bold>To conduct a systematic literature review of the reliability, construct validity, and responsiveness of the SF-36® Health Survey (SF-36) in patients with ulcerative colitis (UC).<bold>Methods: </bold>We performed a systematic search of electronic medical databases to identify published peer-reviewed studies which reported scores from the eight scales and/or two summary measures of the SF-36 collected from adult patients with UC. Study findings relevant to reliability, construct validity, and responsiveness were reviewed.<bold>Results: </bold>Data were extracted and summarized from 43 articles meeting inclusion criteria. Convergent validity was supported by findings that 83% (197/236) of correlations between SF-36 scales and measures of disease symptoms, disease activity, and functioning exceeded the prespecified threshold (r ≥ |0.40|). Known-groups validity was supported by findings of clinically meaningful differences in SF-36 scores between subgroups of patients when classified by disease activity (i.e., active versus inactive), symptom status, and comorbidity status. Responsiveness was supported by findings of clinically meaningful changes in SF-36 scores following treatment in non-comparative trials, and by meaningfully larger improvements in SF-36 scores in treatment arms relative to controls in randomized controlled trials. The sole study of SF-36 reliability found evidence supporting internal consistency (Cronbach's α ≥ 0.70) for all SF-36 scales and test-retest reliability (intraclass correlation coefficient ≥0.70) for six of eight scales.<bold>Conclusions: </bold>Evidence from this systematic literature review indicates that the SF-36 is reliable, valid, and responsive when used with UC patients, supporting the inclusion of the SF-36 as an endpoint in clinical trials for this patient population. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09629343
Volume :
27
Issue :
2
Database :
Complementary Index
Journal :
Quality of Life Research
Publication Type :
Academic Journal
Accession number :
128149483
Full Text :
https://doi.org/10.1007/s11136-017-1690-6